Pyong Woo Park Selected Research

1,7- dioxa- 2,6- diaza- 4,7a- dithia- 3H,5H- benzo(cd)pentalene

12/2020

Syndecan-1 Promotes Streptococcus pneumoniae Corneal Infection by Facilitating the Assembly of Adhesive Fibronectin Fibrils.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pyong Woo Park Research Topics

Disease

11	Infections 01/2022 - 12/2005
10	Inflammation (Inflammations) 01/2022 - 05/2005
4	Hemorrhagic Shock 01/2017 - 01/2011
3	Shock 01/2017 - 09/2013
3	Lung Injury 01/2017 - 02/2009
3	Communicable Diseases (Infectious Diseases) 01/2015 - 01/2010
2	Carcinogenesis 01/2022 - 05/2002
2	Acute Liver Failure (Fulminant Hepatic Failure) 01/2020 - 11/2017
2	Pneumonia (Pneumonitis) 11/2015 - 05/2005
1	Pneumococcal Infections 12/2020
1	Blast Crisis (Blast Phase) 11/2020
1	Leukemia 11/2020
1	Myeloid Leukemia (Leukemia, Myelocytic) 11/2020
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2020
1	Listeriosis (Listeria Infection) 01/2020
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2018
1	Dermatitis 01/2018
1	Bacterial Infections (Bacterial Infection) 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 01/2018
1	Liver Diseases (Liver Disease) 11/2017
1	Disease Progression 11/2017
1	Muscle Cramp (Cramp) 06/2015
1	Wounds and Injuries (Trauma) 09/2013
1	Aneurysm (Aneurysms) 02/2012
1	Aortic Aneurysm (Aneurysm, Aortic) 02/2012
1	Neoplasms (Cancer) 01/2012
1	Endotoxemia 10/2009
1	Staphylococcal Pneumonia 11/2008
1	Cytokine Release Syndrome 07/2008
1	Septic Shock (Toxic Shock Syndrome) 07/2008
1	Vascular System Injuries 07/2008
1	Hypertension (High Blood Pressure) 01/2008
1	Protein-Losing Enteropathies (Protein-Losing Enteropathy) 01/2008
1	Trichinellosis 03/2006
1	Sepsis (Septicemia) 12/2005
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 09/2005
1	Respiratory Hypersensitivity 05/2005
1	Lung Diseases (Lung Disease) 05/2005
1	Eosinophilia 05/2005
1	Wound Infection (Wound Infections) 01/2005
1	Burns 01/2005
1	Pseudomonas Infections 01/2005
1	Acute Lung Injury 11/2002

Drug/Important Bio-Agent (IBA)

21	Syndecan-1 (Syndecan 1)IBA 12/2020 - 05/2002
9	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 01/2022 - 05/2005
4	Heparitin Sulfate (Heparan Sulfate)IBA 01/2020 - 07/2008
3	SyndecansIBA 11/2020 - 12/2005
3	GlycosaminoglycansIBA 01/2016 - 01/2010
3	ChemokinesIBA 10/2009 - 11/2002
2	Pharmaceutical PreparationsIBA 11/2020 - 01/2020
2	Biological ProductsIBA 11/2020 - 02/2010
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2020 - 11/2017
2	Matrix Metalloproteinases (MMPs)IBA 01/2016 - 06/2011
2	Proteoglycans (Proteoglycan)IBA 02/2010 - 03/2006
2	Virulence Factors (Pathogenicity Factors)IBA 02/2010 - 02/2009
2	CXC ChemokinesIBA 10/2009 - 11/2008
2	Proteins (Proteins, Gene)FDA Link 02/2009 - 07/2008
2	Blood Proteins (Serum Proteins)IBA 02/2009 - 01/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2008 - 01/2008
1	1,7- dioxa- 2,6- diaza- 4,7a- dithia- 3H,5H- benzo(cd)pentaleneIBA 12/2020
1	Fibronectins (Fibronectin)IBA 12/2020
1	HMGB1 Protein (HMG1)IBA 01/2020
1	Receptor for Advanced Glycation End ProductsIBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2018
1	CytokinesIBA 01/2018
1	Imiquimod (Aldara)FDA LinkGeneric 01/2018
1	Syndecan-2IBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Syndecan-4IBA 01/2017
1	ADAM17 ProteinIBA 11/2015
1	Ringer's LactateIBA 11/2015
1	CathelicidinsIBA 06/2015
1	Antimicrobial Cationic PeptidesIBA 06/2015
1	Angiotensin IIIBA 02/2012
1	Pancreatic Elastase (Elastase)IBA 02/2012
1	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 02/2009
1	staphylococcal enterotoxin BIBA 07/2008
1	Interleukin-2 (IL2)IBA 07/2008
1	Interleukin-6 (Interleukin 6)IBA 07/2008
1	Muscle Proteins (Muscle Protein)IBA 03/2006
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 09/2005
1	TinIBA 09/2005
1	Monocyte Chemoattractant ProteinsIBA 09/2005
1	Interleukin-4 (Interleukin 4)IBA 05/2005
1	CC ChemokinesIBA 05/2005
1	Glycoproteins (Glycoprotein)IBA 05/2005
1	AllergensIBA 05/2005
1	Protamines (Protamine Sulfate)FDA Link 01/2005
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 11/2002

Therapy/Procedure

4	Resuscitation 01/2017 - 01/2011
1	Therapeutics 11/2020
1	Intranasal Administration 02/2009